Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(8):594-597; doi:10.1093/jnci/92.8.594
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Reynolds, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 8, 594-597, April 19, 2000
© 2000 Oxford University Press

NEWS

Genome Data Announcement Fuels Stock Plunge, Misunderstanding

Tom Reynolds

The Nasdaq stock index took its second steepest dive ever March 14, after President Clinton and British Prime Minister Tony Blair issued a joint statement affirming that human genome data should be freely available to all.

The biotech companies on the Nasdaq lost tens of billions of dollars in value when skittish investors interpreted the Anglo-American announcement as bad news for private-sector genome research, despite the two leaders’ assurance that intellectual property rights would be protected. The stock plunge highlighted the misunderstanding about gene patenting among the public—starting with federal officials and the national news media.

The . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?